Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
6
×
life sciences
national
national blog main
national top stories
novartis
6
×
pfizer
6
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
startups
alzheimer's disease
amgen
biogen
cancer immunotherapy
crispr
crispr therapeutics
eli lilly
gene therapy
What
bio
roundup
drug
gene
acquisitions
biggest
car
ceo
crispr
life
millions
moves
patients
pharmaceutical
science
therapy
typically
access
advanced
albert
alzheimer’s
bails
becker
billions
bourla
brand
bridgebio
build
buy
capacity
capital
cell
companies
company
company’s
consolidation
daniel
debut
develop
different
Language
unset
unknown
Current search:
novartis
×
deals
×
pfizer
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
